| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |